$KVUE
Kenvue Inc.

2023 Q2 Form 10-Q Financial Statement

#000194404823000013 Filed on June 02, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q2
Revenue $3.852B $3.767B $3.590B
YoY Change 7.3% 0.91%
Cost Of Revenue $1.727B $1.693B $1.634B
YoY Change 5.69% -2.48%
Gross Profit $2.125B $2.074B $1.956B
YoY Change 8.64% 3.86%
Gross Profit Margin 55.17% 55.06% 54.48%
Selling, General & Admin $1.502B $1.426B $1.350B
YoY Change 11.26% 4.16%
% of Gross Profit 70.68% 68.76% 69.02%
Research & Development $89.00M $103.0M $88.00M
YoY Change 1.14% 0.98%
% of Gross Profit 4.19% 4.97% 4.5%
Depreciation & Amortization $152.0M $166.0M $165.0M
YoY Change -7.88% -77.29%
% of Gross Profit 7.15% 8.0% 8.44%
Operating Expenses $1.591B $1.529B $1.438B
YoY Change 10.64% 3.94%
Operating Profit $640.0M $545.0M $611.0M
YoY Change 4.75% 3.61%
Interest Expense $1.000M -$19.00M $0.00
YoY Change 280.0%
% of Operating Profit 0.16% -3.49% 0.0%
Other Income/Expense, Net -$31.00M $1.000M
YoY Change -3200.0%
Pretax Income $609.0M $512.0M $612.0M
YoY Change -0.49% -0.97%
Income Tax $279.0M $142.0M $84.00M
% Of Pretax Income 45.81% 27.73% 13.73%
Net Earnings $330.0M $370.0M $528.0M
YoY Change -37.5% -9.98%
Net Earnings / Revenue 8.57% 9.82% 14.71%
Basic Earnings Per Share $0.19 $0.21 $0.31
Diluted Earnings Per Share $0.19 $0.20 $0.31
COMMON SHARES
Basic Shares Outstanding 1.716B shares 1.716B shares
Diluted Shares Outstanding 1.716B shares 1.716B shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.691B $1.231B
YoY Change
Cash & Equivalents $1.691B $1.231B $829.0M
Short-Term Investments
Other Short-Term Assets $175.0M $298.0M
YoY Change
Inventory $2.222B $2.226B
Prepaid Expenses
Receivables $2.109B $2.122B
Other Receivables $0.00 $0.00
Total Short-Term Assets $6.439B $5.877B
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $1.836B $1.820B
YoY Change
Goodwill $9.234B $9.185B
YoY Change -6.37%
Intangibles $9.837B $9.853B
YoY Change
Long-Term Investments
YoY Change
Other Assets $386.0M $581.0M
YoY Change
Total Long-Term Assets $29.16B $21.44B
YoY Change
TOTAL ASSETS
Total Short-Term Assets $6.439B $5.877B
Total Long-Term Assets $29.16B $21.44B
Total Assets $35.60B $27.32B
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.781B $1.829B
YoY Change
Accrued Expenses $987.0M $2.097B
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $4.210B $3.926B
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $7.676B $0.00
YoY Change
Other Long-Term Liabilities $516.0M $941.0M
YoY Change
Total Long-Term Liabilities $516.0M $941.0M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.210B $3.926B
Total Long-Term Liabilities $516.0M $941.0M
Total Liabilities $15.31B $7.295B
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings $0.00
YoY Change
Common Stock $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $20.28B $20.02B $20.47B
YoY Change
Total Liabilities & Shareholders Equity $35.60B $27.32B
YoY Change

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q2
OPERATING ACTIVITIES
Net Income $330.0M $370.0M $528.0M
YoY Change -37.5% -9.98%
Depreciation, Depletion And Amortization $152.0M $166.0M $165.0M
YoY Change -7.88% -77.29%
Cash From Operating Activities $802.0M $644.0M $338.0M
YoY Change 137.28% 92.81%
INVESTING ACTIVITIES
Capital Expenditures $55.00M $159.0M $37.00M
YoY Change 48.65% -46.1%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$8.000M $5.000M
YoY Change -100.0% -106.45%
Cash From Investing Activities -$41.00M -$167.0M -$42.00M
YoY Change -2.38% -2.34%
FINANCING ACTIVITIES
Cash Dividend Paid $0.00
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $7.388B -63.00M -$210.0M
YoY Change -3618.1%
NET CHANGE
Cash From Operating Activities $802.0M 644.0M $338.0M
Cash From Investing Activities -$41.00M -167.0M -$42.00M
Cash From Financing Activities $7.388B -63.00M -$210.0M
Net Change In Cash $8.155B 414.0M $89.00M
YoY Change 9062.92% 153.99%
FREE CASH FLOW
Cash From Operating Activities $802.0M $644.0M $338.0M
Capital Expenditures $55.00M $159.0M $37.00M
Free Cash Flow $747.0M $485.0M $301.0M
YoY Change 148.17% 1143.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001944048
CY2023Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q2 dei Amendment Flag
AmendmentFlag
false
CY2023Q2 dei Document Type
DocumentType
10-Q
CY2023Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q2 dei Document Period End Date
DocumentPeriodEndDate
2023-04-02
CY2023Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q2 dei Entity File Number
EntityFileNumber
001-41697
CY2023Q2 dei Entity Registrant Name
EntityRegistrantName
Kenvue Inc.
CY2023Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
88-1032011
CY2023Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
199 Grandview Road
CY2023Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Skillman
CY2023Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2023Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
08558
CY2023Q2 dei City Area Code
CityAreaCode
908
CY2023Q2 dei Local Phone Number
LocalPhoneNumber
874-1200
CY2023Q2 dei Security12b Title
Security12bTitle
Common Stock, Par Value $0.01
CY2023Q2 dei Trading Symbol
TradingSymbol
KVUE
CY2023Q2 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2023Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q2 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1914894444 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1691000000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1231000000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
38000000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
35000000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2109000000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2122000000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
2222000000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
2226000000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
242000000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
175000000 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
175000000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
123000000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
6439000000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
5877000000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1836000000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1820000000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9837000000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9853000000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
9234000000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
9185000000 usd
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
168000000 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
147000000 usd
CY2023Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
7695000000 usd
CY2023Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
0 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
386000000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
434000000 usd
CY2023Q2 us-gaap Assets
Assets
35595000000 usd
CY2023Q1 us-gaap Assets
Assets
27316000000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1781000000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1829000000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
987000000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
906000000 usd
CY2023Q2 kvue Accrued Rebates Returns And Promotions
AccruedRebatesReturnsAndPromotions
838000000 usd
CY2023Q1 kvue Accrued Rebates Returns And Promotions
AccruedRebatesReturnsAndPromotions
862000000 usd
CY2023Q2 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
604000000 usd
CY2023Q1 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
329000000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4210000000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3926000000 usd
CY2023Q2 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
228000000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
214000000 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
7676000000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
0 usd
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2683000000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2428000000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
516000000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
727000000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
15313000000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
7295000000 usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 kvue Net Parent Investment
NetParentInvestment
25521000000 usd
CY2023Q1 kvue Net Parent Investment
NetParentInvestment
25474000000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5239000000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5453000000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
20282000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
20021000000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
35595000000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27316000000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3852000000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3590000000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1727000000 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1634000000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
2125000000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
1956000000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1502000000 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1350000000 usd
CY2023Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
17000000 usd
CY2022Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
5000000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
640000000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
611000000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-31000000 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1000000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
609000000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
612000000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
279000000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
84000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
330000000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
528000000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1716000000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1716000000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1716000000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1716000000 shares
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
330000000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
528000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
161000000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-280000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-14000000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-3000000 usd
CY2023Q2 kvue Other Comprehensive Income Loss Cash Flow Hedge And Derivatives Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeAndDerivativesGainLossAfterReclassificationAndTax
39000000 usd
CY2022Q2 kvue Other Comprehensive Income Loss Cash Flow Hedge And Derivatives Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeAndDerivativesGainLossAfterReclassificationAndTax
-4000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
214000000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-281000000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
544000000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
247000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
20021000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
330000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
214000000 usd
CY2023Q2 kvue Net Transfer To Affiliate
NetTransferToAffiliate
283000000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
20282000000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
20399000000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
528000000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-281000000 usd
CY2022Q2 kvue Net Transfer To Affiliate
NetTransferToAffiliate
181000000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
20465000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
330000000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
528000000 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
152000000 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
165000000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
35000000 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
35000000 usd
CY2023Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
167000000 usd
CY2022Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
20000000 usd
CY2023Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 usd
CY2022Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
2000000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-23000000 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
60000000 usd
CY2023Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-17000000 usd
CY2022Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
194000000 usd
CY2023Q2 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
13000000 usd
CY2022Q2 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-68000000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-54000000 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-126000000 usd
CY2023Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
52000000 usd
CY2022Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-161000000 usd
CY2023Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
10000000 usd
CY2022Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
6000000 usd
CY2023Q2 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
272000000 usd
CY2022Q2 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
36000000 usd
CY2023Q2 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-189000000 usd
CY2022Q2 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
23000000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
802000000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
338000000 usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
55000000 usd
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
37000000 usd
CY2023Q2 us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
14000000 usd
CY2022Q2 us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
0 usd
CY2023Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 usd
CY2022Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
5000000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-41000000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-42000000 usd
CY2023Q2 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-12000000 usd
CY2022Q2 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
6000000 usd
CY2023Q2 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
7686000000 usd
CY2022Q2 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
CY2023Q2 us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
286000000 usd
CY2022Q2 us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
216000000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7388000000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-210000000 usd
CY2023Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6000000 usd
CY2022Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1231000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
740000000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8155000000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
89000000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9386000000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
829000000 usd
CY2023Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2023Q2 kvue Separation Related Costs
SeparationRelatedCosts
98000000 usd
CY2022Q2 kvue Separation Related Costs
SeparationRelatedCosts
10000000 usd
CY2023Q2 us-gaap Use Of Estimates
UseOfEstimates
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Condensed Combined Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported. Estimates are used when accounting for sales discounts, trade promotions, rebates, allowances and incentives, product liabilities, income taxes and related valuation allowance, withholding taxes, depreciation, amortization, employee benefits, contingencies, allocations of cost and expenses from the Parent and its affiliates, and intangible asset and liability valuations. Actual results may or may not differ from those estimates.</span></div>
CY2023Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
7700000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3198000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4672000000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
89000000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
88000000 usd
CY2023Q2 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period amounts have been reclassified to conform to current year presentation, including the realignment of certain allocations in segment financial results. For additional information on the realignment of certain allocations in segment financial results, see Note 14, “Segments of Business”.</span></div>
CY2023Q2 kvue Supplier Finance Program Obligation Current
SupplierFinanceProgramObligationCurrent
302000000 usd
CY2022Q2 kvue Supplier Finance Program Obligation Current
SupplierFinanceProgramObligationCurrent
293000000 usd
CY2023Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
13142000000 usd
CY2023Q2 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
329000000 usd
CY2023Q1 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
351000000 usd
CY2023Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
129000000 usd
CY2023Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
123000000 usd
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1764000000 usd
CY2023Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1752000000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
2222000000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
2226000000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
7938000000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3305000000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4633000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
7870000000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3305000000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9837000000 usd
CY2023Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
13051000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3198000000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9853000000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
236000000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
304000000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
280000000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
276000000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
272000000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
268000000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
9185000000 usd
CY2023Q2 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
49000000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
9234000000 usd
CY2023Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
75000000 usd
CY2023Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
0 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
7676000000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
0 usd
CY2023Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
11000000 usd
CY2023Q2 us-gaap Interest Income Money Market Deposits
InterestIncomeMoneyMarketDeposits
10000000 usd
CY2023Q2 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
8000000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
214000000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-281000000 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
750000000 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
750000000 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0 usd
CY2023Q2 kvue Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
6250000000 usd
CY2023Q2 us-gaap Defined Benefit Plan Administration Expenses
DefinedBenefitPlanAdministrationExpenses
16000000 usd
CY2022Q2 us-gaap Defined Benefit Plan Administration Expenses
DefinedBenefitPlanAdministrationExpenses
12000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
21000000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-12000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
1000000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
-1000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
13000000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
35000000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
35000000 usd
CY2023Q2 kvue Royalty Income
RoyaltyIncome
7000000 usd
CY2022Q2 kvue Royalty Income
RoyaltyIncome
7000000 usd
CY2023Q2 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
9000000 usd
CY2022Q2 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-2000000 usd
CY2023Q2 us-gaap Other Operating Income
OtherOperatingIncome
1000000 usd
CY2022Q2 us-gaap Other Operating Income
OtherOperatingIncome
0 usd
CY2023Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
17000000 usd
CY2022Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
5000000 usd
CY2023Q2 us-gaap-supplement Foreign Currency Transaction Gain Loss After Tax
ForeignCurrencyTransactionGainLossAfterTax
-16000000 usd
CY2022Q2 us-gaap-supplement Foreign Currency Transaction Gain Loss After Tax
ForeignCurrencyTransactionGainLossAfterTax
7000000 usd
CY2023Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
15000000 usd
CY2022Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
6000000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-31000000 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1000000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.458
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.137
CY2023Q2 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
171000000 usd
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
563000000 usd
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1716160000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1716160000 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
330000000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
528000000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1716000000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1716000000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1716000000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1716000000 shares
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
17000000 usd
CY2023Q2 us-gaap Foreign Currency Cash Flow Hedge Gain Loss Reclassified To Earnings Net
ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
11000000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-3000000 usd
CY2022Q2 us-gaap Foreign Currency Cash Flow Hedge Gain Loss Reclassified To Earnings Net
ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
1000000 usd
CY2023Q2 kvue Other Comprehensive Income Loss Cash Flow Hedge And Derivatives Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeAndDerivativesGainLossAfterReclassificationAndTax
39000000 usd
CY2023Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
56000000 usd
CY2023Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
56000000 usd
CY2023Q2 kvue Number Of Other Companies
NumberOfOtherCompanies
120 company
CY2023Q2 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1
CY2022Q2 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3852000000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3590000000 usd
CY2023Q2 kvue Adjusted Operating Income
AdjustedOperatingIncome
942000000 usd
CY2022Q2 kvue Adjusted Operating Income
AdjustedOperatingIncome
847000000 usd
CY2023Q2 us-gaap Other General Expense
OtherGeneralExpense
69000000 usd
CY2022Q2 us-gaap Other General Expense
OtherGeneralExpense
52000000 usd
CY2023Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
17000000 usd
CY2022Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
5000000 usd
CY2023Q2 us-gaap Restructuring Costs
RestructuringCosts
0 usd
CY2022Q2 us-gaap Restructuring Costs
RestructuringCosts
14000000 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
152000000 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
165000000 usd
CY2023Q2 kvue Separation Related Costs
SeparationRelatedCosts
98000000 usd
CY2022Q2 kvue Separation Related Costs
SeparationRelatedCosts
10000000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
640000000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
611000000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-30000000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
1000000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
0 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
609000000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
612000000 usd
CY2023Q2 kvue Accrued Expenses Current
AccruedExpensesCurrent
564000000 usd
CY2023Q1 kvue Accrued Expenses Current
AccruedExpensesCurrent
447000000 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
156000000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
272000000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
32000000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
35000000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
235000000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
152000000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
987000000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
906000000 usd
CY2023Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
363000000 usd
CY2023Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
584000000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
85000000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
81000000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
68000000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
62000000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
516000000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
727000000 usd

Files In Submission

Name View Source Status
0001944048-23-000013-index-headers.html Edgar Link pending
0001944048-23-000013-index.html Edgar Link pending
0001944048-23-000013.txt Edgar Link pending
0001944048-23-000013-xbrl.zip Edgar Link pending
a1011kenvueincdeferredfeep.htm Edgar Link pending
a20231qex311ceocertificati.htm Edgar Link pending
a20231qex312cfocertificati.htm Edgar Link pending
a20231qex321ceocertificati.htm Edgar Link pending
a20231qex322cfocertificati.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
kvue-20230402.htm Edgar Link pending
kvue-20230402.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
kvue-20230402_cal.xml Edgar Link unprocessable
kvue-20230402_def.xml Edgar Link unprocessable
kvue-20230402_lab.xml Edgar Link unprocessable
kvue-20230402_pre.xml Edgar Link unprocessable
kvue-20230402_htm.xml Edgar Link completed
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable